Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
US8304428B2 · kind B2 · utility
0Cited by
2References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2010 |
| Grant date | Nov 6, 2012 |
| Priority date | — |
| Expiry date | Sep 7, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to heterocyclic compounds that bind to Bcl proteins and inhibit Bcl function, compositions comprising such compounds, and methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.